Hologic to acquire Biotheranostics for $230M | 合法醫療器材資訊網

2021年2月22日 — Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market ... MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, ... Read More

2021年1月5日 — Hologic to Acquire Biotheranostics, Leader in Molecular Tests for Breast and Metastatic Cancers, for Approximately $230 Million. Read More

2021年2月23日 — Hologic completes Biotheranostics acquisition ... Hologic (NSDQ:HOLX) announced that it completed its previously announced acquisition of ... Read More

2021年1月6日 — Hologic to acquire Biotheranostics for $230M ... Hologic (NSDQ:HOLX) announced that it agreed to acquire molecular diagnostic test maker ... Read More

Hologic has now acquired Biotheranostics, developer of two highly differentiated molecular diagnostic tests for breast and metastatic cancers – Breast ... Read More

2021年1月5日 — Hologic to Acquire Biotheranostics, Leader in Molecular Tests for Breast and Metastatic Cancers, for Approximately $230 Million. Read More

2021年2月22日 — Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market. -- Breast Cancer Index™ Added to National ... Read More

2021年2月22日 — Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market - read this article along with other careers ... Read More

2021年1月6日 — Hologic announced late Tuesday its acquisition of Biotheranostics for $230 million, marking the second tuck-in for the medical device maker less ... Read More